tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
TPTX is currently covered by 3 analysts with an average price target of $31.6. This is a potential upside of $31.6 (0%) from yesterday's end of day stock price of $0.
Turning Point Therapeutics's activity chart (see below) currently has 68 price targets and 50 ratings on display. The stock rating distribution of TPTX is 25% BUY and 75% HOLD.
Analysts average stock forecasts to be materialized ratio is 58.57% with an average time for these price targets to be met of 76.08 days.
Highest price target for TPTX is $75, Lowest price target is $26, average price target is $31.6.
Most recent stock forecast was given by ANDREW BERENS from LEERINK on 13-Jun-2022.
Currently out of the existing stock ratings of TPTX, 1 are a BUY (25%), 3 are a HOLD (75%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
76
$-0.01 (-0.01%)
101
1 years 10 months 10 days ago
3/4 (75%)
$1.72 (2.32%)
29
Hold
76
$-0.01 (-0.01%)
1 years 10 months 17 days ago
4/6 (66.67%)
$1.25 (1.67%)
64
Hold
76
$-0.01 (-0.01%)
61
1 years 10 months 20 days ago
4/5 (80%)
$1.41 (1.89%)
73
Hold
45
$-31.01 (-40.80%)
75
2 years 1 months 22 days ago
2/2 (100%)
$14.21 (46.15%)
179
Buy
85
$8.99 (11.83%)
120
2 years 2 months 13 days ago
4/6 (66.67%)
$49.25 (137.76%)
99
What is TPTX (Turning Point Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TPTX (Turning Point Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TPTX (Turning Point Therapeutics)?
Which analyst is the currently most bullish on TPTX (Turning Point Therapeutics)?
Which analyst is the currently most reserved on TPTX (Turning Point Therapeutics)?
